I've been thinking some more...
When the manufacture scale-up of acl's heparin was complete, it had the same molecular structure as Arixtra, so hence it will have exactly the same properties as Arixtra. There are no problems with Arixtra, else gsk in London would have said, & they haven't.
I'm sticking with my good news theory. It's much more enjoyable!
- Forums
- ASX - By Stock
- TSN
- re:trading halt
re:trading halt, page-11
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable